These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 25352393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Lian TY, Jiang X, Jing ZC.
    Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Riociguat for the treatment of pulmonary hypertension.
    Meis T, Behr J.
    Expert Opin Pharmacother; 2014 Nov; 15(16):2419-27. PubMed ID: 25260791
    [Abstract] [Full Text] [Related]

  • 7. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.
    DeSouza SA, Preston IR.
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801
    [Abstract] [Full Text] [Related]

  • 8. Riociguat (Adempas). Chronic thromboembolic pulmonary hypertension with markedly restricted physical activity.
    Prescrire Int; 2015 Nov; 24(165):265-6. PubMed ID: 26688897
    [Abstract] [Full Text] [Related]

  • 9. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
    Kim NH.
    Eur Respir Rev; 2010 Mar; 19(115):68-71. PubMed ID: 20956169
    [Abstract] [Full Text] [Related]

  • 10. Riociguat: Clinical research and evolving role in therapy.
    Klinger JR, Chakinala MM, Langleben D, Rosenkranz S, Sitbon O.
    Br J Clin Pharmacol; 2021 Jul; 87(7):2645-2662. PubMed ID: 33242341
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
    Kenny M, Clarke MM, Pogue KT.
    J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
    [Abstract] [Full Text] [Related]

  • 13. Treatment of pulmonary hypertension with riociguat: a review of current evidence and future perspectives.
    Boutou AK, Pitsiou G.
    Expert Opin Pharmacother; 2020 Jul; 21(10):1145-1155. PubMed ID: 32089012
    [Abstract] [Full Text] [Related]

  • 14. Riociguat for the treatment of pulmonary hypertension: a safety evaluation.
    Binder C, Zotter-Tufaro C, Bonderman D.
    Expert Opin Drug Saf; 2016 Dec; 15(12):1671-1677. PubMed ID: 27750459
    [Abstract] [Full Text] [Related]

  • 15. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.
    Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
    [Abstract] [Full Text] [Related]

  • 16. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].
    Gratsianskaya SE, Valieva ZS, Martynyuk TV.
    Ter Arkh; 2020 Oct 14; 92(9):77-84. PubMed ID: 33346435
    [Abstract] [Full Text] [Related]

  • 17. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension.
    Ghofrani HA, Humbert M, Langleben D, Schermuly R, Stasch JP, Wilkins MR, Klinger JR.
    Chest; 2017 Feb 14; 151(2):468-480. PubMed ID: 27263466
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM, NEW COLLABORATORS LIST.
    Respir Med; 2021 Mar 14; 178():106220. PubMed ID: 33540340
    [Abstract] [Full Text] [Related]

  • 20. REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
    Benza RL, Farber HW, Frost A, Grünig E, Hoeper MM, Busse D, Meier C, Nikkho S, Ghofrani HA.
    J Heart Lung Transplant; 2018 Jul 14; 37(7):836-843. PubMed ID: 29580746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.